Literature DB >> 5466704

Preliminary experiments on the chemistry and pharmacology of cannabis.

E W Gill, W D Paton, R G Pertwee.   

Abstract

Mesh：

Substances：

Year:  1970        PMID： 5466704     DOI： 10.1038/228134a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  48 in total

Review 1.  Cannabinoids and the gastrointestinal tract.

Authors:  R G Pertwee
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Plant cannabinoids: a neglected pharmacological treasure trove.

Authors:  Raphael Mechoulam
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

3.  Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.

Authors:  Adèle Thomas; Lesley A Stevenson; Kerrie N Wease; Martin R Price; Gemma Baillie; Ruth A Ross; Roger G Pertwee
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

Review 4.  Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.

Authors:  John M McPartland; Marnie Duncan; Vincenzo Di Marzo; Roger G Pertwee
Journal:  Br J Pharmacol       Date:  2015-02       Impact factor: 8.739

5.  Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism.

Authors:  W D Paton; R G Pertwee
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

6.  The ring test: a quantitative method for assessing the 'cataleptic' effect of cannabis in mice.

Authors:  R G Pertwee
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

7.  The effect of delta1-tetrahydrocannabinol on the uptake of [3H]-(minus)-noradrenaline by the isolated perfused heart of the rat.

Authors:  J D Graham; M J Lewis; D M Li
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739

Review 8.  The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.

Authors:  R G Pertwee
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

Review 9.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

10.  Interaction of cannabis and general anaesthetic agents in mice.

Authors:  G B Chesher; D M Jackson; G A Starmer
Journal:  Br J Pharmacol       Date:  1974-04       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.